IRE1αは,膀がんにおけるERストレス調節によるM1腫瘍ウイルス感受性を調節する
Cheng Hu1,2, Song Wei1,2, Wenbo Zhu3,2
1Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, Guangdong, China.
Cancer drug resistance (Alhambra, Calif.)
|August 22, 2025
まとめ
IRE1αを阻害すると,筋肉侵襲性膀がんの腫瘍性ウイルス療法が強化され,エンドプラズマ網膜のストレスとM1ウイルス誘発のアポトーシスが促進されます. この戦略は腫瘍抑制を改善し,より良い治療結果をもたらす可能性があります.
科学分野:
- 腫瘍治療ウイルス療法
- 癌 分子 生物学
- 膀 がん 研究
背景:
- 筋肉侵襲性膀がん (MIBC) は,腫瘍の固有の抵抗性により,治療上の大きな課題を提示する.
- 腫瘍解消性ウイルス治療は有望だが,患者の反応の変動によって制限されている.
- 腫瘍解毒ウイルスに対する感受性の違いの分子メカニズムを理解することは,有効性を改善するために極めて重要です.
研究 の 目的:
- 膀がんにおけるM1腫瘍性ウイルスに対する感受性の変動の分子基礎を調査する.
- M1ウイルス誘発の細胞死における,エンドプラズマ網膜 (ER) ストレスと展開タンパク質応答 (UPR) 経路,特にIRE1αの役割を明らかにする.
- IRE1α抑制とM1ウイルス治療を併用する治療の可能性を評価する.
主な方法:
- 異なるM1感受性の膀がん細胞系におけるERストレスとUPR活性化の分析
- siRNAと選択的阻害剤 (STF083010) を使用して IRE1α発現を調節する.
- ウイルス細胞毒性,複製,アポトーシス,および異種移植モデルにおける in vivo 抗腫瘍効果の評価. 患者の細胞とTCGAデータを用いて臨床的関連性について調べました.
主要な成果:
- M1ウイルスはERストレスを誘発し,敏感な細胞系ではアポトーシスを誘発し,より敏感な細胞系では最小限の反応を示した.
- 適度に敏感な細胞では,M1の複製により IRE1αの調節が向上し,ERのストレスとアポトーシスが弱まった.
- IRE1αの抑制は,M1誘発のERストレス,アポトーシス,オンコロシスをインビトロで強化し,毒性が増加することなく腫瘍抑制をインビボで強化した. 患者の腫瘍における IRE1α の低下は,より悪い予後と相関する.
結論:
- IRE1αは,M1ウイルス誘発のタンパク質蓄積と膀がんにおける細胞死亡の調節剤として作用する.
- IRE1αを阻害すると,ERのストレスが増加し,M1ウイルスの腫瘍解消効果が著しく強化されます.
- IRE1αをターゲットにすることは,特にアクセス可能な腫瘍において,M1ベースのウイルス治療結果を改善するための有望な戦略です.
関連する概念動画
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Role of ER in the Secretory Pathway
5.6K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K


